Commodore Capital »

Celldex Therapeutics shares owned by Commodore Capital

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Commodore Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $28M 702k 39.66
2023-09-30 $19M 707k 27.52
2023-06-30 $21M 632k 33.93
2023-03-31 $18M 496k 35.98
2022-12-31 $22M 496k 44.57
2022-09-30 $15M 539k 28.11
2022-06-30 $15M 539k 26.96
2022-03-31 $8.2M 241k 34.06
2021-09-30 $13M 248k 53.99
2021-06-30 $11M 323k 33.44
2021-03-31 $7.6M 370k 20.60
2020-12-31 $6.2M 356k 17.52